Segments - by Product Type (Ethyl Levulinate, Methyl Levulinate, Butyl Levulinate, Others), by Application (Solvents, Plasticizers, Fuel Additives, Pharmaceuticals, Cosmetics, Others), by End-Use Industry (Chemical, Pharmaceutical, Food & Beverage, Cosmetics & Personal Care, Others)
The Bio-Sourced Levulinic Ketal market was valued at USD 137 Million in 2025 and is projected to reach USD 272 Million by 2034, a CAGR of 7.9%.
| Market size (2025) | USD 137 Million |
|---|---|
| Forecast (2034) | USD 272 Million |
| CAGR (2026-2034) | 7.9% |
| Largest region | Asia Pacific (USD 51 Million) |
| Segments covered | Product Type, Application, End-Use Industry |
| Key companies | GF Biochemicals Ltd., Eastman Chemical Company, Avantium N.V., Biofine Technology LLC, Celtic Renewables Ltd. |
This report is updated with the latest market data and insights as of June 2026. Base year: 2025 | Forecast period: 2026-2034
Our analysis shows that the global bio-sourced levulinic ketal market size reached USD 137 million in 2025, registering robust momentum driven by increasing demand for sustainable chemicals across diverse industries. The market is projected to grow at a CAGR of 7.9% from 2026 to 2034, with the forecasted market size expected to reach USD 272 million by 2034. The primary growth factor is the accelerated shift towards renewable and eco-friendly chemical alternatives, propelled by stringent environmental regulations and rising awareness regarding the environmental impact of petrochemical-derived products.
One of the most significant growth drivers for the bio-sourced levulinic ketal market is the mounting global emphasis on sustainability and the circular economy. As industries strive to reduce their carbon footprint and transition towards greener alternatives, bio-based chemicals like levulinic ketals are gaining substantial traction. These compounds, derived from biomass resources such as agricultural waste, offer a renewable and biodegradable substitute for conventional petrochemicals. The increasing adoption of bio-sourced levulinic ketals in applications such as solvents, plasticizers, and fuel additives is a direct result of this sustainability imperative. Furthermore, governmental incentives and funding for bio-based chemical manufacturing are fostering innovation and scale-up, providing a solid foundation for sustained market growth throughout the 2026-2034 forecast period. Parallel demand expansion in the bio-based levulinic ketone sector further validates the strong industrial appetite for biomass-derived platform chemicals.
Another key factor fueling the expansion of the bio-sourced levulinic ketal market is the growing demand in high-performance end-use sectors such as pharmaceuticals, cosmetics, and personal care. These industries are increasingly seeking non-toxic, biodegradable, and high-purity ingredients to meet both regulatory requirements and consumer preferences for safer, more natural products. Levulinic ketals, with their favorable physicochemical properties and low toxicity, are being incorporated into formulations ranging from topical pharmaceuticals to cosmetic emulsifiers and fragrances. This trend is especially pronounced in regions with stringent chemical safety standards, such as Europe and North America, where manufacturers are rapidly replacing legacy ingredients with bio-sourced alternatives.
Technological advancements in biomass conversion and green chemistry are further catalyzing the growth of the bio-sourced levulinic ketal market. Innovations in catalytic processes, feedstock optimization, and process integration have significantly improved the yield, purity, and cost-effectiveness of levulinic ketal production. As a result, manufacturers are now able to offer a broader range of product grades tailored to specific industrial requirements. The ongoing research and development activities are also unlocking new applications for levulinic ketals, such as advanced fuel additives and specialty solvents, which is expected to drive incremental demand through 2034. This technological edge, combined with favorable market dynamics, positions bio-sourced levulinic ketals as a cornerstone of the green chemical industry.
Biomass-Derived Levulinic Acid plays a crucial role in the production of bio-sourced levulinic ketals, serving as a fundamental building block in the synthesis of these sustainable chemicals. Derived from renewable biomass resources, levulinic acid is a versatile platform chemical that offers a pathway to a variety of high-value derivatives, including levulinic ketals. Its production from agricultural waste and other biomass feedstocks not only provides an eco-friendly alternative to petrochemical processes but also contributes to the reduction of greenhouse gas emissions. The utilization of biomass-derived levulinic acid in the chemical industry underscores the growing commitment to sustainable practices and the circular economy, further driving the demand for bio-sourced levulinic ketals across various applications.
Regionally, the Asia Pacific market is emerging as a dominant force in the bio-sourced levulinic ketal landscape, accounting for approximately 37.5% of global demand in 2025. The region's rapid industrialization, coupled with robust government support for bio-based industries and the availability of abundant biomass feedstock, is fueling market expansion. China and India, in particular, are witnessing heightened investment in green chemistry initiatives, making Asia Pacific a focal point for both production and consumption of bio-sourced levulinic ketals. Meanwhile, North America and Europe continue to lead in innovation and regulatory compliance, ensuring steady demand growth and technological leadership in the global market through the forecast horizon.
The bio-sourced levulinic ketal market is segmented by product type into ethyl levulinate, methyl levulinate, butyl levulinate, and others. Among these, ethyl levulinate holds the largest share in 2025 at approximately 38.5%, owing to its versatile application profile and favorable environmental characteristics. Ethyl levulinate is extensively used as a green solvent and fuel additive due to its excellent solvency, low toxicity, and biodegradability. Its compatibility with a wide range of industrial processes makes it a preferred choice for manufacturers seeking to reduce their reliance on petrochemical solvents. The growing emphasis on clean fuel technologies further amplifies the demand for ethyl levulinate, particularly in regions with aggressive carbon reduction targets. Market participants interested in dedicated downstream developments can find additional context in our coverage of the bio-derived ethyl levulinate solvent segment, which reflects aligned growth dynamics.
Methyl levulinate is another prominent product type, accounting for roughly 27% of the 2025 market and gaining traction in pharmaceutical and cosmetic applications. Its low volatility and high purity make it suitable for sensitive formulations where safety and performance are paramount. The pharmaceutical industry, in particular, is leveraging methyl levulinate as an intermediate in the synthesis of active pharmaceutical ingredients (APIs) and excipients. The increasing investment in green pharmaceutical manufacturing, coupled with regulatory support for bio-based ingredients, is expected to drive steady growth in this segment through 2034. Developments in the broader renewable methyl levulinate market continue to reinforce demand signals for this sub-segment.
Butyl levulinate is witnessing growing adoption in the plasticizer and specialty chemicals sectors, representing about 22.5% of the 2025 market. Its unique chemical structure imparts flexibility and durability to polymer matrices, making it an ideal alternative to conventional phthalate-based plasticizers. The rising awareness of the health hazards associated with phthalates is prompting manufacturers to shift towards safer, bio-sourced alternatives like butyl levulinate. Additionally, its use as a fragrance ingredient in personal care products is contributing to incremental demand, especially in markets with stringent safety standards.
The others segment encompasses a range of specialized levulinic ketals tailored for niche applications, including advanced fuel additives and specialty solvents, and accounts for the remaining 12% of the 2025 market. Continuous R&D efforts are leading to the development of novel ketal derivatives with enhanced performance characteristics, opening up new avenues for market expansion. As industrial users seek customized solutions to meet evolving regulatory and performance requirements, the demand for these specialized products is expected to rise, contributing to the overall growth of the bio-sourced levulinic ketal market through 2034.
In summary, the product type segmentation highlights the diverse utility of bio-sourced levulinic ketals across industries. Ethyl levulinate's dominance is complemented by the rising significance of methyl and butyl levulinate in high-value applications. The ongoing innovation in product development and the emergence of new ketal derivatives are expected to further diversify the market, ensuring sustained growth and resilience against market fluctuations over the 2026-2034 forecast horizon.
| Attributes | Details |
| Report Title | Bio-Sourced Levulinic Ketal Market Research Report 2034 |
| By Product Type | Ethyl Levulinate, Methyl Levulinate, Butyl Levulinate, Others |
| By Application | Solvents, Plasticizers, Fuel Additives, Pharmaceuticals, Cosmetics, Others |
| By End-Use Industry | Chemical, Pharmaceutical, Food & Beverage, Cosmetics & Personal Care, Others |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2025 |
| Historic Data | 2019-2024 |
| Forecast Period | 2026-2034 |
| Number of Pages | 279 |
| Number of Tables & Figures | 380 |
| Customization Available | Yes, the report can be customized as per your need. |
The application landscape of the bio-sourced levulinic ketal market is broad, encompassing solvents, plasticizers, fuel additives, pharmaceuticals, cosmetics, and others. Among these, the solvents segment commands a considerable share in 2025, driven by the global shift towards green and sustainable solvents in industrial and consumer applications. Bio-sourced levulinic ketals are increasingly replacing traditional petrochemical solvents in paints, coatings, and cleaning products, owing to their low toxicity, high solvency power, and biodegradability. The regulatory push for VOC reduction and the growing consumer preference for eco-friendly formulations are key factors propelling the demand for levulinic ketal-based solvents through the 2026-2034 period.
The plasticizers segment is another significant application area, particularly in the context of the ongoing phase-out of phthalate-based plasticizers. Bio-sourced levulinic ketals offer an attractive alternative, providing comparable or superior plasticizing efficiency while eliminating the health and environmental risks associated with conventional plasticizers. The adoption of levulinic ketal plasticizers is gaining momentum in the manufacture of flexible PVC, automotive interiors, and food packaging materials. Regulatory mandates in regions like the European Union are accelerating this transition, creating new growth opportunities for market participants. The broader trend also reflects growing industry interest in bio-sourced succinic acid and related sustainable platform chemicals that complement levulinic ketal plasticizer formulations.
In the fuel additives segment, bio-sourced levulinic ketals are being recognized for their ability to enhance fuel performance and reduce emissions. Their high oxygen content and excellent combustion characteristics make them ideal candidates for blending with gasoline and diesel fuels. The increasing focus on renewable and low-carbon fuels, coupled with stringent emission regulations, is driving the adoption of levulinic ketal-based fuel additives through 2034. This trend is particularly pronounced in North America and Europe, where policymakers are actively promoting the use of bio-based fuel components to meet climate targets.
The pharmaceuticals and cosmetics segments are witnessing rapid growth, fueled by the demand for safe, non-toxic, and high-purity ingredients. In pharmaceuticals, levulinic ketals are used as intermediates and excipients, while in cosmetics, they serve as emollients, stabilizers, and fragrance carriers. The clean label movement and rising consumer awareness regarding ingredient safety are catalyzing the adoption of bio-sourced alternatives in these sectors. As manufacturers continue to innovate and expand their product portfolios, the applications of levulinic ketals are expected to diversify further, driving incremental market growth across the forecast period.
The others application segment includes emerging uses such as agrochemicals, lubricants, and specialty chemicals. As research into the functional properties of levulinic ketals advances, new application areas are likely to emerge, further expanding the market's scope. The versatility and performance benefits of these compounds position them as key enablers of sustainable innovation across a wide range of industries through 2034.
The bio-sourced levulinic ketal market serves a diverse array of end-use industries, including chemical, pharmaceutical, food & beverage, cosmetics & personal care, and others. The chemical industry represents the largest end-use segment in 2025, leveraging levulinic ketals as green solvents, intermediates, and plasticizers in various chemical synthesis and formulation processes. The industry's proactive approach to sustainability and compliance with evolving environmental standards is driving the adoption of bio-sourced alternatives. Major chemical manufacturers are increasingly integrating levulinic ketals into their product lines to meet the dual objectives of performance and environmental stewardship.
In the pharmaceutical industry, the demand for levulinic ketals is primarily driven by their use as intermediates in the synthesis of active pharmaceutical ingredients (APIs) and excipients. The industry's stringent quality and safety requirements, coupled with the trend towards green chemistry, are creating robust demand for high-purity, bio-sourced ingredients. Pharmaceutical companies are also exploring the use of levulinic ketals in drug delivery systems and topical formulations, further expanding their application scope. The increasing investment in research and development, along with regulatory support for bio-based pharmaceuticals, is expected to sustain growth in this segment through 2034.
The food & beverage industry is an emerging end-use sector for bio-sourced levulinic ketals, particularly in the context of food packaging and flavor formulation. Levulinic ketals are being evaluated as safe, non-toxic plasticizers and flavor carriers, offering a sustainable alternative to synthetic additives. The industry's focus on clean label products and sustainable packaging solutions is driving the adoption of bio-sourced chemicals. As regulatory agencies continue to tighten restrictions on synthetic additives, the demand for natural and bio-based alternatives like levulinic ketals is expected to rise consistently through the forecast horizon.
The cosmetics & personal care industry is witnessing significant uptake of levulinic ketals, driven by the demand for natural, non-toxic, and high-performance ingredients. These compounds are used as emollients, stabilizers, and fragrance carriers in a wide range of cosmetic formulations. The growing consumer preference for green and sustainable personal care products is prompting manufacturers to reformulate their offerings with bio-sourced ingredients. The industry's dynamic innovation landscape and rapid product development cycles are expected to drive continued growth in this segment through 2034.
The others end-use segment encompasses a variety of niche industries, including agrochemicals, lubricants, and specialty materials. As the functional benefits and sustainability credentials of levulinic ketals become more widely recognized, their adoption in these emerging sectors is expected to accelerate. The ongoing diversification of end-use industries is a testament to the versatility and broad applicability of bio-sourced levulinic ketals, underscoring their potential as a cornerstone of the green chemical economy through 2034.
The bio-sourced levulinic ketal market presents a multitude of opportunities for growth and innovation, largely driven by the global shift towards sustainable and renewable chemicals. One of the most promising opportunities lies in the development of advanced catalytic processes and feedstock optimization techniques, which can significantly enhance the yield, purity, and cost-effectiveness of levulinic ketal production. As research into biomass conversion and green chemistry accelerates, manufacturers have the chance to expand their product portfolios, enter new application areas, and capture a larger share of the value chain. Additionally, the increasing adoption of circular economy principles and the integration of bio-sourced chemicals into existing industrial processes are expected to create new revenue streams and foster long-term market resilience through the 2026-2034 period.
Another key opportunity is the expanding regulatory support for bio-based chemicals across major markets. Governments and regulatory bodies are introducing incentives, subsidies, and mandates to encourage the adoption of sustainable alternatives to petrochemicals. This favorable policy environment is driving investment in bio-sourced chemical manufacturing infrastructure and R&D, enabling market participants to scale up production and accelerate commercialization. The growing consumer preference for eco-friendly products, coupled with the rising demand for clean label ingredients in pharmaceuticals, cosmetics, and food & beverage, further amplifies the market's growth potential. Companies that can effectively leverage these trends and align their strategies with evolving market dynamics are well-positioned to capitalize on emerging opportunities through 2034.
Despite the strong growth prospects, the bio-sourced levulinic ketal market faces certain restraints that could impede its expansion. One of the primary challenges is the relatively high production cost of bio-sourced levulinic ketals compared to their petrochemical counterparts. This cost differential is largely attributable to the complexity of biomass conversion processes and the need for advanced catalytic technologies. Additionally, the availability and consistency of high-quality biomass feedstock can pose supply chain challenges, particularly in regions with underdeveloped agricultural infrastructure. Market participants must therefore invest in process optimization, feedstock diversification, and supply chain integration to overcome these barriers and ensure long-term competitiveness throughout the forecast horizon.
The regional distribution of the bio-sourced levulinic ketal market reflects varying levels of industrialization, regulatory support, and resource availability. Asia Pacific emerged as the leading regional market in 2025, accounting for approximately USD 51 million of the global market size, representing a 37.5% share. The region's rapid industrial growth, abundant biomass resources, and proactive government policies supporting bio-based industries are key drivers of market expansion. China and India, in particular, are investing heavily in green chemistry initiatives, positioning Asia Pacific as a major hub for both production and consumption of bio-sourced levulinic ketals. The region is expected to maintain a strong growth trajectory, with a projected CAGR of 8.8% through 2034, supported by the parallel scaling of related green chemical value chains including bio-sourced methyltetrahydrofuran production infrastructure.
Europe is another significant market, with a strong emphasis on environmental sustainability and regulatory compliance. In 2025, the European market for bio-sourced levulinic ketals was valued at approximately USD 36 million, representing a 26.5% share of global demand, driven by stringent regulations on chemical safety and emissions, as well as robust demand from the pharmaceutical and cosmetics industries. The European Union's Green Deal and circular economy initiatives are fostering innovation and adoption of bio-based chemicals, ensuring steady market growth through 2034. The region's established infrastructure and technological leadership further enhance its competitive position in the global market.
In North America, the market size reached approximately USD 30 million in 2025, representing a 22% share, supported by a mature industrial base, advanced R&D capabilities, and growing consumer awareness of sustainable products. The United States is at the forefront of bio-sourced chemical innovation, with significant investments in research, manufacturing, and commercialization. The region's focus on renewable fuels and green solvents is expected to drive incremental demand for levulinic ketals, particularly in the fuel additives and specialty chemicals segments. Meanwhile, Latin America and the Middle East & Africa are emerging markets with untapped potential, accounting for approximately 7.5% and 6.5% of global demand respectively in 2025. These regions are expected to witness gradual but consistent growth through 2034 as infrastructure development and regulatory frameworks evolve to support the adoption of bio-sourced chemicals.
The competitive landscape of the bio-sourced levulinic ketal market is characterized by a mix of established chemical manufacturers, emerging bio-based specialists, and research-driven organizations. Leading players are focusing on strategic collaborations, mergers and acquisitions, and capacity expansions to strengthen their market position and enhance their product offerings. The market's dynamic nature is fostering intense competition, with companies vying to differentiate themselves through innovation, product quality, and sustainability credentials. Intellectual property protection and proprietary process technologies are key factors influencing competitive advantage, as manufacturers seek to secure their position in high-growth application segments.
Innovation is at the core of the competitive strategy in the bio-sourced levulinic ketal market in 2025. Companies are investing heavily in R&D to develop novel catalytic processes, optimize feedstock utilization, and enhance product performance across a growing range of end-use applications. The ability to offer customized solutions tailored to specific industry requirements is emerging as a critical success factor. Market leaders are also leveraging digitalization and process automation to improve operational efficiency, reduce costs, and accelerate time-to-market for new products. The emphasis on sustainability extends beyond product development to encompass supply chain management, lifecycle assessment, and corporate social responsibility initiatives.
Strategic partnerships and collaborations are playing a pivotal role in shaping the competitive dynamics of the market. Companies are entering into joint ventures with technology providers and downstream users to accelerate innovation, scale up production, and expand market reach. These alliances enable participants to pool resources, share expertise, and mitigate risks associated with technology development and market entry. The growing trend towards open innovation and cross-industry collaboration is expected to drive further consolidation and specialization within the market through the 2026-2034 forecast period.
Some of the major companies operating in the bio-sourced levulinic ketal market include GF Biochemicals Ltd., Eastman Chemical Company, Avantium N.V., Biofine Technology LLC, Celtic Renewables Ltd., and Tokyo Chemical Industry Co., Ltd. GF Biochemicals Ltd. is a pioneer in large-scale production of levulinic acid and its derivatives, with a strong focus on process optimization and sustainability. Avantium N.V. is known for its advanced catalytic technology platforms enabling high-efficiency conversion of biomass to bio-based chemicals, including levulinic ketal intermediates. Celtic Renewables Ltd. specializes in the conversion of distillery by-products and other biomass streams into high-value biochemicals, including levulinic derivatives.
Eastman Chemical Company and DuPont leverage their extensive process chemistry expertise and global distribution networks to supply high-purity levulinic ketal grades for pharmaceutical and specialty chemical customers. Tokyo Chemical Industry Co., Ltd. (TCI) is a leading global supplier of specialty and fine chemicals, maintaining a strong catalog of bio-sourced levulinic ketal products supported by rigorous quality assurance standards. Nippon Shokubai Co., Ltd. and Merck KGaA are also active participants, applying their deep expertise in catalysis and specialty chemicals to develop and commercialize next-generation bio-sourced ketal solutions for industrial and life science markets.
In conclusion, the bio-sourced levulinic ketal market is poised for sustained growth through 2034, driven by innovation, regulatory support, and increasing demand for sustainable chemical solutions. The competitive landscape is expected to evolve rapidly as market participants embrace new technologies, expand their global footprint, and respond to emerging opportunities and challenges in the green chemical economy.
The Bio-Sourced Levulinic Ketal market has been segmented on the basis of
Key trends include the accelerating replacement of phthalate-based plasticizers with bio-sourced alternatives driven by regulatory bans and consumer safety concerns, growing integration of levulinic ketal derivatives into next-generation renewable fuel formulations, rapid expansion of bio-based solvent portfolios among major chemical companies, and increasing cross-industry R&D collaborations targeting novel ketal derivatives. Digitalization of biomass conversion processes, life cycle assessment adoption, and the expanding scope of EU and US bio-economy policy frameworks are also shaping long-term market trajectories through 2034.
In the cosmetics industry, bio-sourced levulinic ketals are used as emollients, fragrance carriers, stabilizers, and skin-conditioning agents in creams, lotions, serums, and hair care products, where their low toxicity and biodegradability align with clean beauty trends. In pharmaceuticals, they serve as high-purity intermediates in the synthesis of active pharmaceutical ingredients (APIs) and as functional excipients in oral and topical drug delivery systems. Their favorable safety profile and compatibility with green manufacturing standards make them increasingly preferred ingredients in both sectors through the 2026-2034 period.
Leading companies in the bio-sourced levulinic ketal market as of 2025 include GF Biochemicals Ltd., Eastman Chemical Company, Avantium N.V., Biofine Technology LLC, Celtic Renewables Ltd., Tokyo Chemical Industry Co. Ltd. (TCI), Merck KGaA, Nippon Shokubai Co. Ltd., Haihang Industry Co. Ltd., Anhui Xinyuan Chemical Co. Ltd., Langfang Triple Well Chemicals Co. Ltd., DuPont, and Parchem Fine and Specialty Chemicals. These firms compete on the basis of process innovation, product purity, sustainability credentials, and global supply chain integration.
Key opportunities include expanding regulatory support for bio-based chemicals, growing investment in advanced biomass conversion technologies, rising demand from high-value pharmaceutical and cosmetics sectors, and increasing adoption of circular economy frameworks across major industrial markets. The primary challenges are the relatively higher production costs compared to petrochemical alternatives, dependence on consistent and high-quality biomass feedstock supply chains, and the need for further scale-up of catalytic conversion processes to achieve price parity with conventional chemical inputs.
Asia Pacific leads the global market with approximately 37.5% share in 2025, valued at around USD 51 million, supported by rapid industrialization, abundant biomass feedstocks, and strong government green chemistry programs in China and India. Europe holds the second-largest share at about 26.5%, driven by strict EU chemical regulations and the Green Deal framework. North America accounts for roughly 22%, led by the United States. Latin America and the Middle East and Africa are emerging markets, collectively representing about 14% of global demand in 2025.
The chemical industry is the largest end-use sector, leveraging levulinic ketals as green solvents, plasticizers, and process intermediates. The pharmaceutical industry is a significant consumer, using them as high-purity intermediates and excipients in drug synthesis and formulation. The cosmetics and personal care industry is the fastest-growing end-user segment, driven by clean-label and sustainability trends. The food and beverage industry is an emerging sector, exploring levulinic ketals for sustainable packaging materials and flavor delivery applications.
The main applications of bio-sourced levulinic ketals include solvents (the largest application segment), plasticizers, fuel additives, pharmaceuticals, and cosmetics. As green solvent substitutes, these compounds are replacing petrochemical-based solvents in paints, coatings, and cleaning products. In fuel additives, their high oxygen content improves combustion efficiency and reduces emissions. Growing utilization in pharmaceutical synthesis and cosmetic formulations as safe, biodegradable excipients and emollients is also driving market diversity through the 2026-2034 forecast period.
Ethyl levulinate holds the largest share at approximately 38.5% of the 2025 market, driven by its widespread use as a green solvent and fuel additive. Methyl levulinate accounts for roughly 27%, with strong demand from pharmaceutical and cosmetic formulation sectors. Butyl levulinate represents about 22.5% of the market, primarily used in plasticizer and personal care applications. The remaining 12% is attributed to other specialized ketal derivatives serving niche industrial and specialty chemical needs.
The primary drivers include the global push toward green chemistry and circular economy principles, tightening environmental regulations on petrochemical solvents and plasticizers, growing consumer demand for clean-label and bio-based ingredients, and technological advances in biomass conversion that have improved production yields and reduced costs. Favorable government incentives for bio-based chemical manufacturing in the US, EU, China, and India are also providing significant momentum through the forecast period.
The global bio-sourced levulinic ketal market reached USD 137 million in 2025, the base year for this report. It is projected to grow at a CAGR of 7.9% during the forecast period of 2026-2034, reaching approximately USD 272 million by 2034. This growth is fueled by accelerating demand for sustainable, renewable chemical alternatives across pharmaceuticals, cosmetics, specialty chemicals, and fuel additive applications worldwide.